Literature DB >> 28637874

Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin.

Esben G W Schmidt1, Michael L Hvam2, Filipa Antunes3, Jason Cameron3, Dorthe Viuff1, Birgitte Andersen1, Nanna N Kristensen1, Kenneth A Howard4.   

Abstract

Albumin is the most abundant plasma protein involved in the transport of many compounds, such as fatty acids, bilirubin, and heme. The endothelial cellular neonatal Fc receptor (FcRn) has been suggested to play a central role in maintaining high albumin plasma levels through a cellular recycling pathway. However, direct mapping of this process is still lacking. This work presents the use of wild-type and engineered recombinant albumins with either decreased or increased FcRn affinity in combination with a low or high FcRn-expressing endothelium cell line to clearly define the FcRn involvement, intracellular pathway, and kinetics of albumin trafficking by flow cytometry, quantitative confocal microscopy, and an albumin-recycling assay. We found that cellular albumin internalization was proportional to FcRn expression and albumin-binding affinity. Albumin accumulation in early endosomes was independent of FcRn-binding affinity, but differences in FcRn-binding affinities significantly affected the albumin distribution between late endosomes and lysosomes. Unlike albumin with low FcRn-binding affinity, albumin with high FcRn-binding affinity was directed less to the lysosomes, suggestive of FcRn-directed albumin salvage from lysosomal degradation. Furthermore, the amount of recycled albumin in cell culture media corresponded to FcRn-binding affinity, with a ∼3.3-fold increase after 1 h for the high FcRn-binding albumin variant compared with wild-type albumin. Together, these findings uncover an FcRn-dependent endosomal cellular-sorting pathway that has great importance in describing fundamental mechanisms of intracellular albumin recycling and the possibility to tune albumin-based therapeutic effects by FcRn-binding affinity.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Fc receptor; albumin; cellular recycling; endosome; intracellular processing; intracellular trafficking; receptor recycling

Mesh:

Substances:

Year:  2017        PMID: 28637874      PMCID: PMC5555191          DOI: 10.1074/jbc.M117.794248

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Megalin and cubilin--the story of two multipurpose receptors unfolds.

Authors:  Pierre J Verroust; Erik I Christensen
Journal:  Nephrol Dial Transplant       Date:  2002-11       Impact factor: 5.992

2.  Preferential interaction of albumin-binding proteins, gp30 and gp18, with conformationally modified albumins. Presence in many cells and tissues with a possible role in catabolism.

Authors:  J E Schnitzer; A Sung; R Horvat; J Bravo
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

Review 3.  Functional and morphological studies of protein transcytosis in continuous endothelia.

Authors:  Dan Predescu; Stephen M Vogel; Asrar B Malik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-11       Impact factor: 5.464

4.  The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states.

Authors:  L M Russo; R M Sandoval; M McKee; T M Osicka; A B Collins; D Brown; B A Molitoris; W D Comper
Journal:  Kidney Int       Date:  2007-01-17       Impact factor: 10.612

5.  Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires co-expressed human beta 2-microglobulin.

Authors:  Steven M Claypool; Bonny L Dickinson; Masaru Yoshida; Wayne I Lencer; Richard S Blumberg
Journal:  J Biol Chem       Date:  2002-05-22       Impact factor: 5.157

6.  The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs.

Authors:  Derry C Roopenian; Gregory J Christianson; Thomas J Sproule; Aaron C Brown; Shreeram Akilesh; Nadja Jung; Stefka Petkova; Lia Avanessian; Eun Young Choi; Daniel J Shaffer; Peter A Eden; Clark L Anderson
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

7.  Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans.

Authors:  E Sally Ward; Jinchun Zhou; Victor Ghetie; Raimund J Ober
Journal:  Int Immunol       Date:  2003-02       Impact factor: 4.823

8.  An albumin-conjugated peptide exhibits potent anti-HIV activity and long in vivo half-life.

Authors:  Dong Xie; Cheng Yao; Li Wang; Wenjie Min; Jiahong Xu; Jiahai Xiao; Mingxian Huang; Bo Chen; Bin Liu; Xiaolin Li; He Jiang
Journal:  Antimicrob Agents Chemother       Date:  2009-10-26       Impact factor: 5.191

9.  Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor.

Authors:  Devin B Tesar; Noreen E Tiangco; Pamela J Bjorkman
Journal:  Traffic       Date:  2006-09       Impact factor: 6.215

10.  The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan.

Authors:  Chaity Chaudhury; Samina Mehnaz; John M Robinson; William L Hayton; Dennis K Pearl; Derry C Roopenian; Clark L Anderson
Journal:  J Exp Med       Date:  2003-02-03       Impact factor: 14.307

View more
  23 in total

1.  Roadmap on nanomedicine.

Authors:  Paolo Decuzzi; Dan Peer; Daniele Di Mascolo; Anna Lisa Palange; Purnima Naresh Manghnani; S Moein Moghimi; Z Shadi Farhangrazi; Kenneth A Howard; Daniel Rosenblum; Tingxizi Liang; Zhaowei Chen; Zejun Wang; Jun-Jie Zhu; Zhen Gu; Netanel Korin; Didier Letourneur; Cédric Chauvierre; Roy van der Meel; Fabian Kiessling; Twan Lammers
Journal:  Nanotechnology       Date:  2021-01-01       Impact factor: 3.874

2.  A new class of recombinant human albumin with multiple surface thiols exhibits stable conjugation and enhanced FcRn binding and blood circulation.

Authors:  Karen Kræmmer Schelde; Karl Nicholls; Frederik Dagnæs-Hansen; Karen Bunting; Helen Rawsthorne; Birgitte Andersen; Christopher J A Finnis; Miranda Williamson; Jason Cameron; Kenneth A Howard
Journal:  J Biol Chem       Date:  2019-01-02       Impact factor: 5.157

3.  Human serum albumin presents isoform variants with altered neonatal Fc receptor interactions.

Authors:  Yann Leblanc; Marie Berger; Alexander Seifert; Nicolas Bihoreau; Guillaume Chevreux
Journal:  Protein Sci       Date:  2019-11       Impact factor: 6.725

4.  A time-to-event analysis of the exposure-response relationship for bezlotoxumab concentrations and CDI recurrence.

Authors:  Ka Lai Yee; Huub Jan Kleijn; Stefan Zajic; Mary Beth Dorr; Rebecca E Wrishko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-02-11       Impact factor: 2.745

5.  Mechanism of how carbamylation reduces albumin binding to FcRn contributing to increased vascular clearance.

Authors:  Shiv Pratap S Yadav; Ruben M Sandoval; Jingfu Zhao; Yifan Huang; Exing Wang; Sudhanshu Kumar; Silvia B Campos-Bilderback; George Rhodes; Yehia Mechref; Bruce A Molitoris; Mark C Wagner
Journal:  Am J Physiol Renal Physiol       Date:  2020-12-07

6.  A human endothelial cell-based recycling assay for screening of FcRn targeted molecules.

Authors:  Algirdas Grevys; Jeannette Nilsen; Kine M K Sand; Muluneh B Daba; Inger Øynebråten; Malin Bern; Martin B McAdam; Stian Foss; Tilman Schlothauer; Terje E Michaelsen; Gregory J Christianson; Derry C Roopenian; Richard S Blumberg; Inger Sandlie; Jan Terje Andersen
Journal:  Nat Commun       Date:  2018-02-12       Impact factor: 14.919

7.  Half-life-extended recombinant coagulation factor IX-albumin fusion protein is recycled via the FcRn-mediated pathway.

Authors:  Jenny Chia; Jade Louber; Isabelle Glauser; Shirley Taylor; Greg T Bass; Steve K Dower; Paul A Gleeson; Anne M Verhagen
Journal:  J Biol Chem       Date:  2018-03-09       Impact factor: 5.157

Review 8.  The Neonatal Fc Receptor (FcRn): A Misnomer?

Authors:  Michal Pyzik; Kine M K Sand; Jonathan J Hubbard; Jan Terje Andersen; Inger Sandlie; Richard S Blumberg
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

9.  An Albumin-Oligonucleotide Assembly for Potential Combinatorial Drug Delivery and Half-Life Extension Applications.

Authors:  Matthias Kuhlmann; Jonas B R Hamming; Anders Voldum; Georgia Tsakiridou; Maja T Larsen; Julie S Schmøkel; Emil Sohn; Konrad Bienk; David Schaffert; Esben S Sørensen; Jesper Wengel; Daniel M Dupont; Kenneth A Howard
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-07

10.  Human and mouse albumin bind their respective neonatal Fc receptors differently.

Authors:  Jeannette Nilsen; Malin Bern; Kine Marita Knudsen Sand; Algirdas Grevys; Bjørn Dalhus; Inger Sandlie; Jan Terje Andersen
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.